JPMORGAN CHASE & CO - IRONWOOD PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$2,641,000
-0.3%
2,537,0000.0%0.00%
Q4 2021$2,649,000
-3.2%
2,537,000
+1.5%
0.00%
Q3 2021$2,736,000
+25.4%
2,500,000
+25.0%
0.00%
Q2 2021$2,182,000
-31.9%
2,000,000
-34.3%
0.00%
-100.0%
Q2 2020$3,205,000
-29.9%
3,045,000
-30.9%
0.00%0.0%
Q1 2020$4,574,000
+74.8%
4,408,000
+97.4%
0.00%
Q4 2019$2,616,000
-47.5%
2,233,000
-55.2%
0.00%
-100.0%
Q3 2019$4,981,000
+368.1%
4,985,000
+398.5%
0.00%
Q2 2019$1,064,000
+17633.3%
1,000,000
+19900.0%
0.00%
Q1 2019$6,000
-99.5%
5,000
-99.6%
0.00%
Q4 2018$1,139,000
-74.2%
1,206,000
-64.8%
0.00%
-100.0%
Q3 2018$4,420,000
+531.4%
3,422,000
+553.1%
0.00%
Q2 2018$700,000
+16.3%
524,000
+2.7%
0.00%
Q1 2018$602,000
+352.6%
510,000
+351.3%
0.00%
Q4 2017$133,000
-96.7%
113,000
-96.7%
0.00%
-100.0%
Q3 2017$4,067,000
+412.2%
3,374,000
+458.6%
0.00%
Q2 2017$794,000
-8.0%
604,000
-12.6%
0.00%
Q1 2017$863,000
-66.2%
691,000
-69.1%
0.00%
-100.0%
Q4 2016$2,550,000
+47.3%
2,237,000
+53.5%
0.00%
Q3 2016$1,731,000
-54.6%
1,457,000
-60.3%
0.00%
-100.0%
Q2 2016$3,809,0003,666,0000.00%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
K2 PRINCIPAL FUND, L.P. 9,000$9,953,0000.83%
CSS LLC/IL 10,119,000$11,031,0000.46%
DeepCurrents Investment Group LLC 13,556,000$14,917,0000.45%
TENOR CAPITAL MANAGEMENT Co., L.P. 10,000,000$11,014,0000.24%
WOLVERINE ASSET MANAGEMENT LLC 28,592,000$31,218,0000.24%
HBK INVESTMENTS L P 14,616,000$15,971,0000.06%
PALISADE CAPITAL MANAGEMENT, LP 2,127,000$2,334,0000.05%
Verition Fund Management LLC 3,942,000$4,304,0000.04%
LAZARD ASSET MANAGEMENT LLC 10,037,000$10,959,0000.01%
Calamos Advisors LLC 2,423,000$2,648,0000.01%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders